Helius Therapeutics Revenue and Competitors

East Tamaki,

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Helius Therapeutics's estimated annual revenue is currently $6.2M per year.(i)
  • Helius Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Helius Therapeutics has 40 Employees.(i)
  • Helius Therapeutics grew their employee count by 5% last year.

Helius Therapeutics's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Regulatory Affairs and QA OfficerReveal Email/Phone
3
QA OfficerReveal Email/Phone
4
Chief Quality OfficerReveal Email/Phone
5
Chief Commercial Officer (CCO)Reveal Email/Phone
6
Chief Operating OfficerReveal Email/Phone
7
Chief Financial OfficerReveal Email/Phone
8
Quality ManagerReveal Email/Phone
9
Product Development ManagerReveal Email/Phone
10
Extraction ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is Helius Therapeutics?

Helius Therapeutics exists to help people improve their quality of life through world-class medicinal cannabis products. We are a New Zealand-owned company with facilities in Auckland. Helius specialises in the cultivation, research and manufacturing of GMP-certified medicinal cannabis products. Our executive management team comprises leading professionals from horticulture, consumer goods, marketing, operations and financial sectors. One of our founders is a pioneer of the US medicinal cannabis industry, bringing unprecedented scientific capability and specialist intellectual property to our enterprise. New Zealand is rich in horticultural expertise and renowned for its innovation. Helius is fusing local hydroponic growing techniques with world-class cannabis research and development experience from North America. We pride ourselves on bringing a high level of commercial professionalism to this nascent industry, and we believe in its enormous potential. Helius exists to create a naturally healthier society and shares a vision of improving the quality of life for all New Zealanders who can benefit from locally-produced, affordable medicinal cannabis.

keywords:N/A

N/A

Total Funding

40

Number of Employees

$6.2M

Revenue (est)

5%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Helius Therapeutics News

2022-04-17 - New Licence - Great News For Kiwi Cannabis Patients ...

It's an exciting milestone,” says Carmen Doran, chief executive of Helius Therapeutics. Helius CEO, Carmen Doran. Helius Extraction Manager,...

2022-04-13 - Engineers To Drive Better Outcomes For Cannabis Patients ...

New Zealand's largest medicinal cannabis company, Helius Therapeutics, has launched an industry collaboration with the University of...

2022-04-06 - Organic Medicinal Cannabis A Huge Opportunity For NZ ...

... taking the country's newest industry to a whole new level in the future,” says Carmen Doran, chief executive of Helius Therapeutics.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.9M4940%N/A
#2
$19.6M688%N/A
#3
$21.1M8646%N/A
#4
$25.9M15767%N/A
#5
$39.7M16422%N/A